NUP37, a positive regulator of YAP/TEAD signaling, promotes the progression of hepatocellular carcinoma

Xiaoling Luo, Yuting Liu, Weiguang Feng, Lei Liu, Yemu Du, Jinsheng Wu, Shaochuang Wang

Oncotarget · 2017 · 36 citations · 12 references

DOIFull text

Open access

Concepts

Abstract

// Xiaoling Luo 1, * , Yuting Liu 3, * , Weiguang Feng 2 , Liu Lei 3 , Yemu Du 3 , Jinsheng Wu 3 and Shaochuang Wang 3 1 Department of Gastroenterology, Huai’an First People’s Hospital, Nanjing Medical University, Huai’an, Jiangsu Province 223300, P. R. China 2 The Fourth People’s Hospital of Huai’an, Huai’an, Jiangsu Province 223002, P. R. China 3 Department of Hepatobiliary & Pancreatic Surgery, Huai’an First People’s Hospital, Nanjing Medical University, Huai’an, Jiangsu Province 223300, P. R. China * These authors are defined as co-first author Correspondence to: Shaochuang Wang, email: wangshaochuang26@sina.com Keywords: NUP37; YAP/TEAD signaling; cell growth and motility; hepatocellular carcinoma Received: October 02, 2016      Accepted: July 24, 2017      Published: August 18, 2017 ABSTRACT Activation of YAP/TEAD signaling is very common in the progression of HCC (Hepatocellular carcinoma). Nuclear pore complex (NPC) regulates the shuttling of proteins between cytoplasm and nucleus. Nuclear accumulation of YAP protein has been observed in the majority of HCC tissues. However, whether NPC could regulate the YAP/TEAD signaling remains unknown. In this study, it was found NUP37, the component of NPC, significantly up-regulated in HCC clinical samples and mouse model. Over-expression of NUP37 promoted the growth, migration and invasion of HCC cells, while knocking down the expression of NUP37 inhibited the growth, migration, invasion and metastasis of HCC cells and improved the survival of the mouse model. NUP37 interacted with YAP and activated YAP/TEAD signaling by enhancing the interaction between YAP and TEAD. Taken together, these data demonstrated the oncogenic roles of NUP37 in the progression of HCC and suggested that NUP37 might be a promising therapeutic target.

References

12